Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance Evaluation of MagIA In-vitro Diagnostic Medical Device for Multiplex Screening of Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C and Syphilis in Sub-Saharan Africa

NCT07170748 is registered in ClinicalTrials.gov with MagIA Diagnostics as lead sponsor.

NCT NCT07170748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07170748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance Evaluation of MagIA In-vitro Diagnostic Medical Device for Multiplex Screening of Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C and Syphilis in Sub-Saharan Africa
Lead sponsor
MagIA Diagnostics
Phase
Observational
Overall status
Recruiting
Start date
July 29, 2025
Completion date
April 30, 2026
Enrollment
2,950 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hbv, hcv, hiv, multiplex testing of hiv, hbv, hcv and syphilis, point of care testing, syphilis